严重创伤及高血栓栓塞事件风险患者中预防性下腔静脉滤器的当代应用
本研究基于创伤质量改进项目(2010-2019)数据,纳入544739例严重颅内、骨盆或下肢及脊髓损伤成人患者,评估预防性下腔静脉滤器植入与院内深静脉血栓、肺栓塞及死亡率的关系。结果显示预防性滤器植入与静脉血栓栓塞风险增加相关;在未接受药物性静脉血栓栓塞预防的患者中,预防性滤器植入与院内死亡率降低相关。
要点
- 预防性下腔静脉滤器植入与深静脉血栓和肺栓塞风险增加相关。
- 在未接受药物性静脉血栓栓塞预防的患者中,预防性滤器植入与院内死亡率降低相关。
- 在接受药物性静脉血栓栓塞预防的患者中,预防性滤器植入与死亡率无显著关联。
核心结论
- 在所有严重颅内、骨盆或下肢及脊髓损伤成人中,预防性下腔静脉滤器植入与静脉血栓栓塞可能性增加相关;在未接受药物性静脉血栓栓塞预防的患者中,预防性滤器植入与院内死亡率降低相关。
研究设计与样本
- 回顾性队列研究,基于创伤质量改进项目(2010-2019)数据,纳入544739例18岁及以上严重颅内、骨盆或下肢或脊髓损伤患者;预防性下腔静脉滤器定义为入院后≤72小时内且在下肢超声检查前植入。
诊断标准与关键数值
- 在接受药物性静脉血栓栓塞预防的患者中,预防性下腔静脉滤器植入与期待管理相比,深静脉血栓的比值比为4.30(P < .001),肺栓塞的比值比为4.30(P < .001),死亡率的比值比为0.92(P = .43)。
- 在未接受药物性静脉血栓栓塞预防的患者中,预防性下腔静脉滤器植入与深静脉血栓的比值比为4.63(P < .001),肺栓塞的比值比为5.02(P < .001),死亡率的比值比为0.43(P < .001)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aim of this study was to evaluate the relationship between prophylactic inferior vena cava filter (IVCF) implantation and in-hospital deep vein thrombosis (DVT), pulmonary embolism (PE), and mortality among adults with intracranial, pelvic or lower extremity, and spinal cord injuries.
METHODS: Patients 18 years and older with severe intracranial, pelvic or lower extremity, or spinal cord injuries captured by the Trauma Quality Improvement Program (2010-2019) were identified. IVCFs implanted ≤72 hours after hospital presentation and before performance of lower extremity ultrasonography were defined as prophylactic. Patients were stratified by pharmacologic venous thromboembolism (VTE) prophylaxis status. Logistic regression models estimated prophylactic inferior vena cava (IVC) filtration's effect on selected outcomes and identified attributes associated with prophylactic IVCF implantation.
RESULTS: Of 544,739 included patients, 1.3% (n = 7,247) underwent prophylactic IVCF implantation. Among patients who received pharmacologic VTE prophylaxis, prophylactic IVC filtration compared with expectant management was positively associated with DVT (odds ratio [OR], 4.30; P < .001) and PE (OR, 4.30; P < .001) but not associated with mortality (OR, 0.92; P = .43). Among patients who received no pharmacologic prophylaxis, prophylactic IVC filtration was positively associated with DVT (OR, 4.63; P < .001) and PE (OR, 5.02; P < .001) but negatively associated with mortality (OR, 0.43; P < .001).
CONCLUSIONS: Prophylactic IVC filtration was associated with increased likelihood of VTE among all adults with severe intracranial, pelvic or lower extremity, and spinal cord injuries. In patients who received no pharmacologic VTE prophylaxis, prophylactic IVC filtration was associated with decreased likelihood of in-hospital mortality.
引用
- Ryce AL, Lee SJ, Ahmed O, et al. Contemporary Use of Prophylactic Inferior Vena Cava Filters in Patients With Severe Traumatic Injuries and High Thromboembolic Event Risk. J Am Coll Radiol. 2023. PMID: 38157951. doi:10.1016/j.jacr.2023.12.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。